Everything below concerns Preclinical research. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-07-28. Where a claim depends on a specific study, the study is described rather than over-claimed.
Published literature on cardarine includes in vitro assays, rodent experiments, and a small number of human studies. Reports describe effects on exercise capacity and lipid metabolism in animals, while human evidence is sparse. Many online descriptions present the compound as a proven endurance aid, a claim not supported by regulatory approval or large clinical trials. Analytical studies focus on identifying the parent compound and its metabolites in biological samples. Important uncertainties include species differences, dose-response relationships, and the relevance of rodent tumor findings to humans.
Cardarine is the common name for GW501516, a synthetic compound studied as a peroxisome proliferator-activated receptor delta agonist. Researchers developed it to explore treatments for lipid disorders and metabolic conditions. It is not an approved medicine in any country. Early clinical work examined changes in HDL cholesterol and triglycerides, but development was discontinued after animal studies raised concerns about cancer. The compound remains available as a research chemical and appears in discussions of performance enhancement.
At the molecular level, GW501516 binds and activates PPARδ, a nuclear receptor that regulates transcription. Activation shifts expression of genes involved in fatty acid oxidation, energy expenditure, and lipid transport in skeletal muscle and liver. Animal studies report increased endurance and altered lipid profiles after exposure. Human data are limited to small trials and do not establish long-term safety or efficacy. PPARδ also has roles in cell proliferation, so the relationship between activation and cancer risk remains an open question.
Published studies have examined GW501516 in animal models of obesity, insulin resistance, and exercise endurance. Early human trials reportedly ended, and development was discontinued after preclinical findings raised concerns about cancer in some rodent studies. Regulatory agencies have not approved cardarine for any medical use. Its availability through non-pharmaceutical channels raises questions about identity, purity, and legal status that are separate from its laboratory pharmacology. Those questions are often addressed through analytical testing rather than assumptions about product labels.
Cardarine is a common name for GW501516, also GW-1516, a synthetic compound developed as a peroxisome proliferator-activated receptor delta (PPARδ) agonist. It belongs to a class of agents that modulate gene transcription related to lipid and energy metabolism. The compound was studied in preclinical and early clinical research for metabolic and cardiovascular conditions, but it did not progress to approved therapeutic use. Its name appears in fitness and sports contexts despite not being approved as a drug.
| Property | Value | Notes |
|---|---|---|
| Common name | Cardarine | Also called GW501516 and endurobol. |
| Chemical formula | C21H18F3NO3S2 | Molecular weight about 453.5 g/mol. |
| Appearance | White to off-white solid | Form depends on synthesis and purity. |
| Solubility | Soluble in DMSO and ethanol | Low solubility in water. |
| Typical storage | -20 °C, desiccated, protected from light | Common for research chemicals. |
Clinical development stopped after rodent studies showed tumors at multiple sites. Whether those findings predict human cancer risk remains an open question, but they led sponsors to discontinue programs. Human safety data are limited to small, short-term studies that were not designed to assess cancer risk. Reported effects in those studies included changes in blood lipids, but the evidence is insufficient for medical use. Long-term consequences of nonmedical use are not well characterized. Questions about dose, duration, and individual susceptibility remain unresolved.
Cardarine is a common name for GW501516, an investigational compound developed in the 1990s for metabolic conditions. It acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in lipid and energy metabolism. The compound is frequently mislabeled as a selective androgen receptor modulator, or SARM, but its molecular target is different. GW501516 reached early clinical testing before development was discontinued. It has no approved therapeutic use in any country. The name cardarine is not a formal international nonproprietary name.
Regulatory treatment varies, but cardarine is not approved as a medicine. Sports authorities list GW501516 as a prohibited substance, and it is banned at all times under the World Anti-Doping Agency code. Many countries restrict sales for human consumption, while online vendors market it as a research chemical. Such products may lack purity data, and their actual contents can differ from the label. Purchasing or possessing cardarine may carry legal consequences depending on jurisdiction. The compound is not a dietary supplement ingredient in regulated markets.
PPARδ is a nuclear receptor that regulates gene expression related to fatty acid oxidation, glucose homeostasis, and mitochondrial function. GW501516 binds to this receptor with high affinity and activates downstream signaling in skeletal muscle and other tissues. Animal studies reported increased endurance and altered fuel preference, but human data remain limited and inconsistent. The precise relationship between receptor activation and observed physiological changes is still an area of active investigation. Researchers have also examined whether the compound affects inflammation or cell proliferation. No approved therapeutic indication exists for cardarine.
In laboratory settings, cardarine is studied as a tool compound for probing PPARδ biology. Published experiments often use cell cultures, rodent models, or isolated tissues. Some investigations focus on metabolic effects, while others assess potential risks such as carcinogenicity observed in long-term animal studies. Because human trials are sparse, most knowledge comes from preclinical work and adverse event reports. Scientific literature frequently notes the gap between animal findings and human outcomes. The compound is not a dietary supplement and is not intended for human consumption.
Cardarine is a common name for GW501516, a synthetic compound developed in the 1990s through research collaborations involving GlaxoSmithKline. It belongs to a class of molecules known as peroxisome proliferator-activated receptor delta agonists. Early studies explored its effects on lipid metabolism and energy expenditure in animal models. The compound was never approved as a human medicine, and clinical development was discontinued. In the years since, it has appeared in fitness and bodybuilding communities as a performance-enhancing substance. Regulatory agencies classify it as an unapproved drug.
Evocative/suppression testing refers to a class of tests performed where one substance is measured both before and after the administration of another substance to determine if the levels are stimulated ("evocative") or suppressed. They are most commonly performed in the evaluation of possible endocrine disorders. Certain tests are performed in the evaluation of multiple conditions, and not all listed substances may be measured in each test. Examples include:
These were a mixture of formed units and individuals. In Tony Blair's Strategic Defence Review of 1998, the TA's size was reduced to 41,200. In 2003, 9,500 reservists were mobilised to take part in Operation TELIC, the invasion of Iraq. Reservists were deployed in a mixture of formed bodies and as individuals. For example, a formed sub-unit from 131 Commando Squadron Royal Engineers opened up a beach landing point on the Al Faw Peninsula and then two further crossing points on sequential watercourses for tanks in the attack on Basra. The Royal Yeomanry mobilised Regimental Headquarters (RHQ) and two sub-units to deliver the UK's Chemical, Radiological, Biological, and Nuclear counter-measures for Operation TELIC. At the peak in 2004, reservists made up 20% of Britain's strength in Iraq. In Afghanistan too, large numbers of reservists deployed in a mixture of formed units and as individuals, until 2009 when the decision was taken to allow only individuals to deploy as reinforcements for regular units. One example of a formed body was Somme Company of The London regiment of whom Brigadier (later Lieutenant-General Sir) John Lorimer remarked: "Somme Company was an outstanding body of men: well trained, highly motivated and exceptionally well led." Approximately 1,200 members of the Army Reserve deployed annually on tours of duty in Iraq, Operation HERRICK in Afghanistan and elsewhere, normally on six-month-long roulements.
Dimerization and oligomerization processes have been observed and attributed to several molecular mechanisms, including intermolecular disulfide formation, bridging through metals bound by either Cys or His residues on different MTs, or inorganic phosphate-mediated interactions. Dimeric and polymeric MTs have been shown to acquire novel properties upon metal detoxification, but the physiological significance of these processes has been demonstrated only in the case of prokaryotic Synechococcus SmtA. The MT dimer produced by this organism forms structures similar to zinc fingers and has Zn-regulatory activity. Metallothioneins have diverse metal-binding preferences, which have been associated with functional specificity. As an example, the mouse MT1 preferentially binds divalent metal ions (Zn(II), Cd(II),...), while yeast CUP1 is selective for monovalent metal ions (Cu(I), Ag(I),...). Strictly metal-selective MTs with metal-specific physiological functions were discovered by Dallinger et al. (1997) in pulmonate snails (Gastropoda, Mollusca). The Roman snail (Helix pomatia), for example, possesses a Cd-selective (CdMT) and a Cu-selective isoform (CuMT) involved in Cd detoxification and Cu regulation, respectively. While both isoforms contain unvaried numbers and positions of Cys residues responsible for metal ligation, metal selectivity is apparently achieved by sequence modulation of amino acid residues not directly involved in metal binding (Palacios et al. 2011).
As early as 1960, ZAPU's predecessor, the National Democratic Party (NDP), had established informal contacts with the Soviet Union and Czechoslovakia, and discussed the possibility of obtaining military training in Eastern Europe for its members. In July 1962, Nkomo visited Moscow and discussed plans for a ZAPU-led armed uprising in Rhodesia. He made formal requests for Soviet funding and arms for ZIPRA, explaining that "for these purposes ZAPU needs arms, explosives, revolvers...the party also needs money to bribe persons who guard important installations, to carry out sabotage". The Soviets agreed to supply ZAPU with limited funds beginning in 1963, and increased its level of financial support after UDI. In 1963, ZIPRA also made its first formal request to the Soviet Union for military training. The Soviets began training ZIPRA militants in guerrilla warfare in early 1964. Nkomo's public endorsement of a violent strategy confirmed white politicians' opposition to ZAPU and fed their negative attitudes towards black nationalists at large. In response to the formation of ZIPRA, the Rhodesian government banned ZAPU, driving that party's supporters underground. It also passed draconian security legislation restricting the right to assembly and granting the security forces broad powers to crack down on suspected political subversives. For the first time, the death sentence was also introduced for any act of politically inspired terrorism which involved arson or the use of explosives.
=== As a medication target === Circulating levels of adiponectin can indirectly be increased through lifestyle modifications and certain medications such as statins. A small molecule adiponectin receptor AdipoR1 and AdipoR2 agonist, AdipoRon, has been reported. In 2016, the University of Tokyo announced it was launching an investigation into anonymously made claims of fabricated and falsified data on AdipoR1, AdipoR2, and AdipoRon. Extracts of sweet potatoes have been reported to increase levels of adiponectin and thereby improve glycemic control in humans. However, a systematic review concluded there is insufficient evidence to support the consumption of sweet potatoes to treat type 2 diabetes mellitus. Adiponectin is apparently able to cross the blood-brain-barrier. However, conflicting data on this issue exist. Adiponectin has a half-life of 2.5 hours in humans.
Sources: en.wikipedia.org
=== Brand names === Finasteride is marketed primarily under the brand names Propecia, for pattern hair loss, and Proscar, for BPH, both of which are products of Merck & Co. There is 1 mg of finasteride in Propecia and 5 mg in Proscar. Merck's patent on finasteride for the treatment of BPH expired in June 2006. Merck was awarded a separate patent for the use of finasteride to treat pattern hair loss and it expired in November 2013. Finasteride is also marketed under a variety of other brand names throughout the world.
=== National Tariff Commission === The National Tariff Commission (Urdu: قومی ماموریہ برائے درآمدی محصول, abbreviated at NTC) advises the Government of Pakistan on tariff measures or other form of assistance to provide protection to indigenous industry and promoting exports. Measures to counter dumping and other unfair measures adopted in respect of import and sale of foreign goods in Pakistan.
=== Climate === Most of Germany has a temperate climate, ranging from oceanic in the north and west to continental in the east and southeast. A small portion is humid subtropical. Winters range from cold in the Southern Alps to cool and are generally overcast with limited precipitation, while summers can vary from hot and dry to cool and rainy. The northern regions have prevailing westerly winds that bring in moist air from the North Sea, moderating the temperature and increasing precipitation. Conversely, the southeast regions have more extreme temperatures. Climate change in Germany is leading to long-term impacts on agriculture, more intense heat waves and cold waves, flash and coastal flooding, and reduced water availability. From February 2019–February 2020, average monthly temperatures in Germany ranged from a low of 3.3 °C (37.9 °F) in January 2020 to a high of 19.8 °C (67.6 °F) in June 2019. Average monthly precipitation ranged from 30 litres per square metre in February and April 2019 to 125 litres per square metre in February 2020. Average monthly hours of sunshine ranged from 45 in November 2019 to 300 in June 2019.
=== Communication === Communication is a vital part of the diagnostic process. The Internist uses both synchronous and asynchronous communication with other members of the medical care team, including other internists, radiologists, specialists, and laboratory technicians. Tools to evaluate teamwork exist and have been employed in multiple settings. Communication to the patient is also important to ensure there is informed consent and shared decision-making throughout the diagnostic process.
=== Direct Chemical Synthesis === Although the focus has primarily been on enzymatic approaches for overcoming length limitations with oligonucleotide synthesis, a proposed alternative is direct chemical synthesis. Standard oligo-synthesis is done on porous materials, such as controlled pore glass (CPG). However, this environment introduces challenges as sequence length increases. Longer strands take up more space within the pores and limit reagent access, which results in lower coupling efficiency and a greater number of truncated sequences in a solution. One innovative approach includes chemically synthesizing the oligonucleotides on a smooth surface, as opposed to porous material, to improve coupling efficiency while additionally utilizing the purification strategy, catching-by-polymerization (CBP), to selectively isolate full-length oligos in a solution. Performing chemical synthesis on a smooth surface, such as glass wool or glass beads, reduces steric strain and congestion, thus providing alternative solid support benefitting long-oligos.
Sources: en.wikipedia.org
Cardarine is a common name for the investigational compound GW501516. It acts as a PPARδ agonist and is not approved for human use. It is prohibited in sport.
It activates PPARδ, a nuclear receptor that influences gene expression related to lipid and energy metabolism. Animal studies show changes in endurance and lipid levels. Human effects and risks are not well established.
No, cardarine is not a steroid. It belongs to a different chemical class, the PPARδ agonists. It is also not a selective androgen receptor modulator.
Cardarine is commonly known as GW501516 or GW-1516. These names refer to the same synthetic compound. It is not a brand-name approved medicine.